<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03176342</url>
  </required_header>
  <id_info>
    <org_study_id>204/59</org_study_id>
    <nct_id>NCT03176342</nct_id>
  </id_info>
  <brief_title>Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)</brief_title>
  <official_title>Drug Patch Tests, Enzyme-linked Immunosorbent Spot Assay (Elispot) and Lymphocyte Transformation Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is about drug patch tests in patients who have history of severe cutaneous drug
      reaction including Steven Johnson syndrome (SJS), toxic epidermal necrolysis (TEN),
      Drug-induced eosinophilia and systemic symptoms (DRESS), AGEP (Acute generalized
      exanthematous pustulosis) and generalized bullous fixed drug eruptions. This study also
      investigate in Enzyme-linked immunosorbent spot assay (ELIspot) and lymphocyte transformation
      test. We also trying to prove the correlation among result of drug patch tests, ELIspot and
      LTT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 4, 2016</start_date>
  <completion_date type="Anticipated">August 3, 2017</completion_date>
  <primary_completion_date type="Anticipated">August 3, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of positive drug patch test results.</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation of drug patch test results, ELIspot and lymphocyte transformation test.</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Drug Reaction</condition>
  <arm_group>
    <arm_group_label>patch test arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patch test by selected allergens and drawing blood for ELIspot and LTT</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>patch test</intervention_name>
    <description>Patch test allergen from chemotechnique diagnostics, pure drug and drug as is combine with petrolatum or aqueous.</description>
    <arm_group_label>patch test arm</arm_group_label>
    <other_name>Enzyme-linked immunosorbent spot assay (ELIspot) and lymphocyte transformation test (LTT)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with history of Steven Johnson syndrome (SJS), toxic epidermal necrolysis
             (TEN), drug-induced eosinophilia and systemic symptoms (DRESS), acute generalized
             exanthematous pustulosis (AGEP), generalized bullous fixed drug eruption in the past
             24 months.

          -  Age more than 18 years old

        Exclusion Criteria:

          -  Receiving immunosuppressive drugs or more than 10 mg/day of prednisolone within 1
             month.

          -  Pregnancy and lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Division of Dermatology, Faculty of Medicine, Chulalongkorn University</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pawinee Rerknimitr, MD, MSc</last_name>
      <phone>+6622564253</phone>
      <email>pawineererk@yahoo.co.th</email>
    </contact>
    <investigator>
      <last_name>Jettanong Klaewsongkram, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Suwimon Pootongkam, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prattana Sittiwattanawong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2017</study_first_submitted>
  <study_first_submitted_qc>June 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2017</study_first_posted>
  <last_update_submitted>June 3, 2017</last_update_submitted>
  <last_update_submitted_qc>June 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Pawinee Rerknimitr</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Drug patch tests</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug-Related Side Effects and Adverse Reactions</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

